Rocket Pharmaceuticals, Inc. Warrant Share Price

Rocket Pharmaceuticals, Inc. Warrant Share Price

NASDAQ: RCKTW
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Rocket Pharmaceuticals, Inc. Warrant Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Rocket Pharmaceuticals, Inc. Warrant Share Price Chart

$0.00$0.00
L
Show Current Price
H

Rocket Pharmaceuticals, Inc. Warrant Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
-4.68%
Profit Margin
N/A
Debt to Equity
0.06
Quarterly Earnings Growth YoY
344.80%

Rocket Pharmaceuticals, Inc. Warrant Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$50.33-$42.54-$47.59$123.21
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A15.48%-11.87%358.90%

Rocket Pharmaceuticals, Inc. Warrant Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$0.00$0.00$0.00
Net Profit-$245.60-$258.75-$223.12
Net Profit MarginN/AN/AN/A
Income ChangeN/A-5.35%13.77%

About Rocket Pharmaceuticals, Inc. Warrant

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Rocket Pharmaceuticals, Inc. Warrant Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

RCKTW Share Price FAQs